{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02967757","recordId":"NCT02967757","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02967757-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02967757.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02967757.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-11-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-16","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"63f3f895976deb76094a3c5e0c7d5bbf5bd40f5b7852656849db77ca2c860a45","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-18","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"8bddc372618246d882ae3cb9c2328dc885cbb4045230743322cd5b919d921f44","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-12-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2016-12-06","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"afb3d06221bf89e711dc98fc49cb2d1082a5c3c06201bf089d871ec9c6e20c7d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-12-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2016-12-27","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"18ae0a4694b82be350df624aa2012a216740cd5103b63de490a969a8115e8729","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-03-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-03-29","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"b9f23c1cb528b8809f23ff332960bfd26f43e6b8ecc5fa9fea114fc5a324f43e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=5&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-05-11","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"0ac31c1643586213a9a03b12433601f79f0e963c851d3df9530829a766aa5596","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=6&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2017-06-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-06-22","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"c9946846ca03f6cc6582abd7ed62e5338b7782e5c25a0ef6aa65536c4d299cc5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=7&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-06-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-06-29","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"efebbc8dbd100844f1e3a4f88f98747ef39f256fa8a75f3228f55baa767cc0ad","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=8&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2017-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-07-24","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"1101420ad3524e425a9fce2ac37f1cd7f6747eb42cab2bd8d3c34dba2e8fb4f3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=9&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-09-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-28","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"500fa8c3619f3c078a69a6998a2863a6b5c413df4b60a7c166484e95a34b23aa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=10&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-10-10","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"6aee311ff05572216fa05901f78eef1aa374d0102bf337079d6fcb1afcfb1803","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=11&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-10-25","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"9fa834e3ab1d22af7a3f1b1061156f3854f141d8ea128ae1f2071e6d09244f41","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=12&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2018-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-03-12","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"52253c1ff8d3a038564365c9e450e2fcebf867434bac6019e20c5b44463ee308","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=13&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2018-07-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-07-12","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"1dab98eba980100d0c28f6b5e17341df5312e4c52bc4d86a485c4c8dadcbc281","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=14&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Design","Study Identification","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2018-09-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-09-14","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"a950e7ce3991b23a25f664da56d2e2dea7afe012195b64cac6cf76b56f02ee14","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=15&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2018-11-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-11-13","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"c3fb82e583ce8297454df3ac1eb7b34980e3a950108df112470d511b1572a61b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=16&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2018-11-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2018-11-20","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"3ef9b6552470df3fef6f9e29ae04ffa0b4ed81a1ee3eb408544e552b273b7cd5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=17&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2019-01-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2019-01-17","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"4eb50c4fc3cecb08428cc096b9b7123a4a69597ca4812354b55fed16f9307212","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=18&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2019-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2019-02-04","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"9a5385338c5b4713cf9085735056500ccb15ec6ef07885eb190ccbc75595610e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=19&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2019-07-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-07-03","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"da2c5365b9cc7a2d8fb5f0c7cb5a34c32b7464f4445ab028a5855823079ffd5d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=20&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2019-08-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-08-02","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"62a4bbb0b7f68eb622633a5279705c6ae80c36b24cb1ab9c32d7d8e4f24fd20d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=21&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["References","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2023-01-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-01-19","publishedAt":"2026-08-23","recordId":"NCT02967757","recordSha256":"8ba256cf5a638144baa9f37410e797b01c758488a4d5dde17abab84d0a0361fc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02967757?a=22&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"86929287f3354328dfb1092ad3b575ca0f11f5c420834ce9d3165ce0e8a8b4fe"}}